Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?

Habibi, Roojin; Lexchin, Joel; Mintzes, Barbara; Holbrook, Anne

doi:10.1111/bcp.13360

Cited by 4 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In some settings, professionals may lack independent and science‐based continuing education. Promotional information overestimates the benefits of drugs and emphasises positive study results but often omits or minimises the risks . The use of drugs such as mood modifiers, availability of drugs without a medical prescription, and biased media or internet information addressed to patients can also influence expectations about drug benefits.…”

Section: Adrsmentioning

confidence: 99%

“…Moreover, most of the promotional information is biased. Two studies performed in developed countries found that almost half of the information supplied by pharmaceutical sales representatives made claims beyond the regulator‐approved efficacy information for the product, while mentioning rarely serious adverse events (5–6%), although 45% of promotions had US Food and Drug Administration black box warnings of serious risks . Some information referred to possible ADRs is not easily accessible and can be found only in complex scientific and regulatory information.…”

Section: How To Get Access To Independent and Reliable Information Onmentioning

confidence: 99%

See 1 more Smart Citation

Undergraduate and postgraduate pharmacovigilance education: A proposal for appropriate curriculum content

Comoglio

2020

Brit J Clinical Pharma

View full text Add to dashboard Cite

Background Adverse drug reactions (ADRs) are common, often preventable, and a leading cause of morbidity and mortality. Pharmacovigilance (PV) involves detection, assessment, understanding, and prevention of adverse effects or any other drug‐related problem. Education of healthcare professionals (HCPs) involved in drug prescription, dispensing and administration is essential to help prevent and mitigate both ADRs and medication errors and has to be focused on 3 pivotal aspects: •Awareness: All medicines can produce adverse effects. ADRs should always be considered as part of the differential diagnosis if any new adverse condition, symptoms or signs appear after a drug administration or during or after pharmacological treatment. •Knowledge: HCPs must have a sound understanding of the most frequently prescribed drugs and over‐the‐counter medications, factors that make patients more likely to benefit or more susceptible to harm, as well as of causes of medication errors. •Reporting: HCPs should know how to report ADRs and the role of reporting on regulatory aspects and scientific knowledge. Undergraduate curricula must provide, at a minimum, sufficient skills that warrant the appropriate and safe prescription/dispensing/administration of medications in clinical practice, focusing both on therapeutic effects and prevention of harm. Clinical appraisal skills must include ADRs as differential diagnosis, taking accurate medication history, basic individual causality assessment, identification and proper management of ADRs, and informing patients of possible ADRs. Postgraduate periodic PV training should be mandatory as part of continuing education. Specialised postgraduate education should include advanced contents.

show abstract

Section: Adrsmentioning

confidence: 99%

Section: How To Get Access To Independent and Reliable Information Onmentioning

confidence: 99%